GOODNEWS MCFIBERESIMA: Open Payments
NPI 1679287817 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $1,600 · 2025 $161
Food & beverage: $161
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $58 |
| Janssen Pharmaceuticals, Inc | 1 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: FANAPT, INVEGA SUSTENNA, UZEDY, REXULTI, VRAYLAR, TRINTELLIX.
Industry payments across PA — which companies pay providers there.
